Revenue up 21% to Rs. 484 Cr; PAT up 6% to Rs. 87 Cr.
Bengaluru, 22nd January, 2019: Syngene International Limited today announced its third quarter financial results for FY19. The Company posted quarterly revenue of Rs. 484 Cr, an increase of 21% from the year-ago quarter. Commenting on the results, Mr. Jonathan Hunt, Chief Executive Officer – Syngene International Limited, said “Revenue performance for the quarter was strong, with revenue increasing 21%, from Rs. 399 Cr last year to Rs. 484 Cr this quarter. We saw accelerating growth in our Discovery Services and Biologics businesses, as well as, the expansion of our strategic collaboration with Merck KGaA and the commissioning of a new facility for Baxter Inc., one of our key Dedicated Centre partners. During the quarter, we continued to invest in strengthening our safety processes as well as make investments in operational excellence and sales and marketing. Our year-to-date performance gives us confidence that we are on track to end the year on plan.”